123 related articles for article (PubMed ID: 2577014)
1. [The bioavailability of nifedipine in different solid pharmaceutical preparations for oral use].
Leucuta SE; Vida-Simiti L; Mocan A; Făgărăşan E; Bugnariu S; Baloescu C; Olinic N; Vlaicu R
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):521-8. PubMed ID: 2577014
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers.
Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R
Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014
[TBL] [Abstract][Full Text] [Related]
3. [Nifedipine pharmacokinetics in liver cirrhosis patients after the administration of a single oral dose].
Leucuţa SE; Grigorescu M; Dumitraşcu D
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1990; 42(2):185-90. PubMed ID: 1982192
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the acute antihypertensive effect of Adalat capsules and Corinfar dragées, two different nifedipine preparations.
Kiss I; Farsang C
Cor Vasa; 1988; 30(2):105-9. PubMed ID: 3391034
[TBL] [Abstract][Full Text] [Related]
5. [Comparative human pharmacokinetic studies of 20 mg nifedipine-containing Cordaflex and Adalat film coated retared tablets].
Klebovich I; Horvai G; Grézal G; Baloghné NK; Horváth V; Kocsi E; Balogh J; Cseh A; Farsang C
Acta Pharm Hung; 1996 Jan; 66(1):29-39. PubMed ID: 8714363
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products.
Shaheen O; Zmeili S; al-Qussuois Y; Arafat T; Mouti H
Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):337-41. PubMed ID: 1937993
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets].
Vidal-Gárate J; Castañeda Hernández G; Hoyo Vadillo C; Herrera Abarca JE; Salazar LA; Moreno Ramos A; Fortino Chávez J; Tena I; Hong E
Arch Inst Cardiol Mex; 1989; 59(1):73-80. PubMed ID: 2486739
[TBL] [Abstract][Full Text] [Related]
8. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.
Leucuta SE
Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376
[TBL] [Abstract][Full Text] [Related]
9. Relative bioavailability of four controlled-release nifedipine products.
Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Van Dyk M; Van Schalkwyk AM
Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987
[TBL] [Abstract][Full Text] [Related]
10. [Clinical pharmacokinetics of the nifedipine preparations Adalat, Corinfar and Cordafen-Polfa].
Marzec A; Bogdan M; Jankowski A; Nartowicz E; Wichliński LM
Kardiol Pol; 1987; 30 Suppl():65-71. PubMed ID: 3454387
[No Abstract] [Full Text] [Related]
11. Bioavailability of indomethacin tablets in men volunteers.
Groth PE; Dunn JM
Clin Pharm; 1986 Oct; 5(10):820-4. PubMed ID: 3780150
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and acute side-effects of nifedipine given as slow-release tablets or liquid-filled capsules.
Saano V; Raatikainen O; Paronen P; Komulainen H
Int J Clin Pharmacol Res; 1989; 9(4):247-54. PubMed ID: 2777428
[TBL] [Abstract][Full Text] [Related]
13. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state].
Meyer FP; Banditt P
Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of ergoloid mesylates liquid capsule.
Schran HF
Clin Ther; 1985; 8(1):71-5. PubMed ID: 3833371
[TBL] [Abstract][Full Text] [Related]
15. [The biological availability of digitoxin].
Vöhringer HF; Wogenstein HM; Rietbrock N
Fortschr Med; 1977 Oct; 95(38):2323-5, 2328-31. PubMed ID: 914188
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of nifedipine: a comparison between two preparations.
Zylber-Katz E; Koren G; Granit L; Levy M
Biopharm Drug Dispos; 1984; 5(2):109-15. PubMed ID: 6743779
[TBL] [Abstract][Full Text] [Related]
17. The pharmaceutical and biological availability of commercial preparations of furosemide.
Stüber W; Mutschler E; Steinbach D
Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
[TBL] [Abstract][Full Text] [Related]
18. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
[TBL] [Abstract][Full Text] [Related]
19. [Bioavailability of peroral drug forms of oxacillin].
Batuashvili TA; Shchedrin VI; Zak AF
Antibiotiki; 1979 Aug; 24(8):611-5. PubMed ID: 485110
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and relative bioavailability of lomefloxacin preparations in 10 healthy Chinese volunteers.
Diao Y; Lu J; Li L; Zhu XD; Ji G; Wang EH
Zhongguo Yao Li Xue Bao; 1993 May; 14(3):247-9. PubMed ID: 8237402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]